Suzhou Xinbao Pharmaceutic Co., Ltd., established in 1975, is a high- and new-tech enterprise mainly engaged in the R & D, manufacture and sales of genetic engineering medicines and bio-chem medicines. We got the GMP certificate of China in January, 2001 in the first time, and we got this certificated again in 2005; at the same time, our production lines (injection, solid preparations) got the GMP certificates too.

Located in the eastern side of Suzhou in Jiangsu in the south of the lower reaches of the Changjiang River, the company boasts top-notch technicians, advanced production equipments as well as 5 production lines in freeze-dried powder for injection, Small Dose Injection, solid formulations, genetic engineering products and bio-chem APIs respectively; moreover, we have over 30 licenses to produce antivirus drug, antineoplastic medicine, drugs for hepatitis B, anti-clotting drug, antihypoxic, antisterility drug, drug for microcirculatory disturbance, drug for brain hear-losing. On December, 1st, 2004, our company was purchased by Shanghai Sansheng Hongye Investment Group. In October, 2007, we purchased 85mu of lands in Jinqiao Development Park in Mudu in Wuzhong district in Suzhou city to expand our factory, a modern pharmaceutical factory will be built up soon. As a technological-intensive and knowledge-intensive enterprise and platform for Sansheng Hongye to enter and develop biological technical industry, our company will invest more in HR and technology for establishing our company to be a development base of biological engineering drugs and biochemical drug.

The company boasts a high-standard Q.C. system to ensure our conformity to the national quality standard. Our product, namely the recombinated Interferon α-2b, with high quality, has not only enjoyed a high reputation in the domestic market, but also exported to distant markets area and so on Africa, Southeast Asia in the world.

We have been always attaching great importance to the development of new products, and over the years, we have developed the following leading products:

Antivirus drugs-- Gene Engineering drug "recombinated Interferon α-2b", which is very effective to hepatitis B;
"Doctor for blood vessels"--two main members of the enzyme family, namely "urokinase and pancreatic kininogenase", which are the main drugs for the treatment of Cardiovascular /cerebrovascular diseases;

Our other products enjoy good reputation and popularity for high technical level and excellent quality, including thrombin, Defibrase, hyaluronidase, zonolysin, adetphos, sodium heparin, calcium heparin, chondroitin sulfate and Compound Cerebroprotein hydrolysate Tablets, etc.

The company, under the principle of “Quality First, Honesty Foremost”, will seek wide cooperation in the pharmaceutical world to establish mutual-benefited partner relationships and to offer the human beings with high-quality bio-chem and genetic engineering drugs.